Identification of C1R as A Potential Drug Target Or Biomarker for Various Diseases

Target Name: C1R

NCBI ID: G715

Content of Review Report on C1R Target / Biomarker

C1R

Identification of C1R as A Potential Drug Target Or Biomarker for Various Diseases

C1R, also known as C1R variant 1, is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a member of the C1r family of proteins, which are involved in various cellular processes, including signaling, DNA replication, and stress response.

Recent studies have identified C1R as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because C1R has been shown to play a role in the development and progression of these conditions, and may be involved in the regulation of important cellular processes that are disrupted in these diseases.

One of the key functions of C1R is its role in the regulation of DNA replication. C1R is a transcription factor that has been shown to play a role in the regulation of DNA replication in various cell types. This is important because DNA replication is a critical process that is required for the development and growth of most organisms, and is also critical for the regulation of gene expression and cellular processes.

In addition to its role in DNA replication, C1R has also been shown to be involved in the regulation of stress response. Stress can have a negative impact on cellular processes and contribute to the development of various diseases, including cancer. C1R has been shown to play a role in the regulation of stress response by helping to maintain the integrity of cellular membranes and the regulation of cellular signaling pathways.

Another function of C1R is its role in the regulation of cell signaling pathways. C1R has been shown to play a role in the regulation of various signaling pathways, including T cell signaling pathways, which are involved in the regulation of immune response, and angiogenesis, which is the process of the formation of new blood vessels.

In conclusion, C1R is a protein that has been shown to play a role in various cellular processes that are important for the development and progression of various diseases. As a result, C1R has potential as a drug target or biomarker for these conditions. Further research is needed to fully understand the role of C1R in these processes and to develop effective treatments for these diseases.

Protein Name: Complement C1r

Functions: C1r B chain is a serine protease that combines with C1q and C1s to form C1, the first component of the classical pathway of the complement system

The "C1R Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1R comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets